Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Chenguang Biotech Group
300138
5
Shanghai Menon Animal Nutrition Technology
301156
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 287.38%148.14M | 287.38%148.14M | -24.81%38.23M | -4.67%38.14M | -10.54%45.75M | -39.10%38.24M | -39.10%38.24M | -53.45%50.85M | -1.20%40.01M | 128.74%51.14M |
-Cash and cash equivalents | 287.38%148.14M | 287.38%148.14M | -24.81%38.23M | -4.67%38.14M | -10.54%45.75M | -39.10%38.24M | -39.10%38.24M | -53.45%50.85M | -1.20%40.01M | 128.74%51.14M |
Prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 181.36%2.14M | 2,324.68%13.07M | 66.21%1.1M |
Restricted cash | -4.53%244.63M | -4.53%244.63M | -42.39%227.57M | --164.94M | --205.65M | --256.24M | --256.24M | --395.01M | ---- | ---- |
Other current assets | 40.88%2.94M | 40.88%2.94M | 949.21%1.32M | 711.97%2.1M | 582.26%3.19M | 81.81%2.09M | 81.81%2.09M | -76.97%126K | -43.94%259K | 27.87%468K |
Total current assets | 31.17%412.57M | 31.17%412.57M | -42.16%271.37M | 320.05%224.06M | 438.63%283.92M | 391.92%314.53M | 391.92%314.53M | 324.47%469.18M | 28.53%53.34M | 125.39%52.71M |
Non current assets | ||||||||||
Net PPE | 98.81%5.19B | 98.81%5.19B | 137.48%4.5B | 1,359.37%3.9B | 1,257.79%3.33B | 1,085.06%2.61B | 1,085.06%2.61B | 929.72%1.89B | 49.64%267.38M | 39.55%245.09M |
-Gross PPE | 98.80%5.19B | 98.80%5.19B | 137.41%4.5B | 1,353.77%3.9B | 1,252.13%3.33B | 1,080.20%2.61B | 1,080.20%2.61B | 924.91%1.89B | 49.47%268.46M | 39.44%246.13M |
-Accumulated depreciation | -68.48%-1.98M | -68.48%-1.98M | -21.55%-1.37M | 30.53%-751K | 75.19%-259K | -16.70%-1.17M | -16.70%-1.17M | -15.42%-1.12M | -15.86%-1.08M | -17.17%-1.04M |
Financial assets | --472.06M | --472.06M | ---- | --257.62M | --175.7M | --0 | --0 | --130.61M | ---- | ---- |
Non current deferred assets | -18.45%317.79M | -18.45%317.79M | -15.23%340.49M | --357.9M | --371.47M | --389.7M | --389.7M | --401.67M | ---- | ---- |
Other non current assets | 41.16%15.56M | 41.16%15.56M | 346.14%15.56M | -51.49%15.56M | -43.36%17.05M | -61.16%11.02M | -61.16%11.02M | -86.74%3.49M | 30.54%32.07M | 32.86%30.11M |
Total non current assets | 99.10%5.99B | 99.10%5.99B | 99.76%4.85B | 1,413.84%4.53B | 1,314.26%3.89B | 1,111.02%3.01B | 1,111.02%3.01B | 1,055.77%2.43B | 47.33%299.45M | 38.79%275.19M |
Total assets | 92.67%6.4B | 92.67%6.4B | 76.78%5.12B | 1,248.46%4.76B | 1,173.50%4.18B | 963.85%3.32B | 963.85%3.32B | 803.73%2.9B | 44.14%352.79M | 47.92%327.91M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 0.62%244.64M | 0.62%244.64M | -31.35%224.36M | 928.48%131.8M | 9,359.76%175.38M | 22,328.87%243.13M | 22,328.87%243.13M | 6,587.50%326.82M | 780.15%12.82M | 259.30%1.85M |
-accounts payable | 0.62%244.64M | 0.62%244.64M | -31.35%224.36M | 928.48%131.8M | 9,359.76%175.38M | 22,328.87%243.13M | 22,328.87%243.13M | 6,587.50%326.82M | 780.15%12.82M | 259.30%1.85M |
Current accrued expenses | 12.56%334.14M | 12.56%334.14M | 55.67%320.02M | 2,371.84%357.97M | 1,123.88%319.05M | 1,695.36%296.85M | 1,695.36%296.85M | 3,127.78%205.58M | 466.59%14.48M | 1,804.24%26.07M |
Current debt and capital lease obligation | -8.34%2.88M | -8.34%2.88M | -14.56%2.89M | 348.90%2.85M | 240.44%2.97M | 187.56%3.14M | 187.56%3.14M | 249.07%3.38M | -34.16%634K | 98.41%873K |
-Current capital lease obligation | -8.34%2.88M | -8.34%2.88M | -14.56%2.89M | 348.90%2.85M | 240.44%2.97M | 187.56%3.14M | 187.56%3.14M | 249.07%3.38M | -34.16%634K | 98.41%873K |
Other current liabilities | ---- | ---- | ---- | ---- | 43.71%5.3M | ---- | ---- | --7.36M | --12.1M | 12.00%3.69M |
Current liabilities | 7.73%595.08M | 7.73%595.08M | 1.38%558.27M | 1,002.58%499.56M | 1,349.19%505.65M | 2,078.10%552.39M | 2,078.10%552.39M | 3,134.46%550.67M | 472.36%45.31M | 381.67%34.89M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 107.14%4.06B | 107.14%4.06B | 126.40%3.46B | 899,850.15%2.98B | 642,734.43%2.54B | 421,892.04%1.96B | 421,892.04%1.96B | 1,068,545.45%1.53B | -9.07%331K | --395K |
-Long term debt | 115.85%3.92B | 115.85%3.92B | 139.91%3.32B | --2.83B | --2.39B | --1.82B | --1.82B | --1.38B | ---- | ---- |
-Long term capital lease obligation | -1.23%144.16M | -1.23%144.16M | -1.20%144.59M | 43,714.50%145.03M | 36,726.84%145.47M | 31,289.68%145.96M | 31,289.68%145.96M | 102,234.27%146.34M | -9.07%331K | --395K |
Derivative product liabilities | --0 | --0 | --60.22M | --0 | --0 | --66.9M | --66.9M | ---- | --84.06M | ---- |
Preferred securities outside stock equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 13.78%215.86M | 13.69%209.13M |
Other non current liabilities | ---- | ---- | ---- | ---- | ---- | -93.90%1.82M | -93.90%1.82M | -93.75%1.95M | -5.45%26.91M | -12.96%26.65M |
Total non current liabilities | 100.13%4.06B | 100.13%4.06B | 130.05%3.52B | 810.51%2.98B | 975.12%2.54B | 772.80%2.03B | 772.80%2.03B | 573.07%1.53B | 49.70%327.16M | 10.07%236.18M |
Total liabilities | 80.37%4.66B | 80.37%4.66B | 96.00%4.08B | 833.88%3.48B | 1,023.27%3.04B | 901.08%2.58B | 901.08%2.58B | 751.52%2.08B | 64.47%372.47M | 22.21%271.07M |
Shareholders'equity | ||||||||||
Share capital | 0.00%26K | 0.00%26K | 0.00%26K | 62.50%26K | 73.33%26K | 85.71%26K | 85.71%26K | 85.71%26K | 23.08%16K | 25.00%15K |
-common stock | 0.00%26K | 0.00%26K | 0.00%26K | 62.50%26K | 73.33%26K | 85.71%26K | 85.71%26K | 85.71%26K | 23.08%16K | 25.00%15K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -15.76%-453.52M | -15.76%-453.52M | -97.79%-519.2M | -4.82%-396M | -41.14%-363.43M | -70.23%-391.77M | -70.23%-391.77M | -24.28%-262.51M | -96.33%-377.78M | -41.86%-257.49M |
Paid-in capital | 22.80%852.05M | 22.80%852.05M | 60.51%1.21B | 187.62%1.04B | 181.49%897.81M | 140.03%693.88M | 140.03%693.88M | 158.39%753.67M | 69.70%362.74M | 74.15%318.94M |
Less: Treasury stock | 47.15%20.92M | 47.15%20.92M | 46.48%20.79M | 208.50%14.37M | 208.76%14.31M | 209.88%14.21M | 209.88%14.21M | 243.93%14.19M | 51.84%4.66M | 160.48%4.63M |
Total stockholders'equity | 31.16%377.64M | 31.16%377.64M | 40.42%669.79M | 3,315.95%632.96M | 815.08%520.1M | 429.55%287.92M | 429.55%287.92M | 524.70%477M | -207.69%-19.68M | 42,200.74%56.84M |
Noncontrolling interests | 202.04%1.37B | 202.04%1.37B | 10.36%375.94M | --645.82M | --610.94M | --452.51M | --452.51M | --340.64M | ---- | ---- |
Total equity | 135.59%1.74B | 135.59%1.74B | 27.90%1.05B | 6,597.23%1.28B | 1,890.00%1.13B | 1,261.82%740.43M | 1,261.82%740.43M | 970.82%817.64M | -207.69%-19.68M | 42,200.74%56.84M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |